UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$351M |
| 2 |
Cisco
CSCO
|
+$313M |
| 3 |
Coca-Cola
KO
|
+$283M |
| 4 |
Estee Lauder
EL
|
+$268M |
| 5 |
TUYA
Tuya Inc
TUYA
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.16B |
| 2 |
TAL Education Group
TAL
|
+$1.92B |
| 3 |
Alibaba
BABA
|
+$1.88B |
| 4 |
Procter & Gamble
PG
|
+$640M |
| 5 |
New Oriental
EDU
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.72% |
| 2 | Healthcare | 12.81% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTH
1351
DELISTED
Genetron Holdings Limited ADS
GTH
| $4.74M | ﹤0.01% |
78,517
+2,069
| +3% | +$128K |
|
1352
CONMED
CNMD
$1.47B
| $4.72M | ﹤0.01% |
34,360
-164
| -0.5% | -$22.5K |
|
|
CIXX
1353
DELISTED
CI Financial Corp.
CIXX
| $4.72M | ﹤0.01% |
256,775
-110,954
| -30% | -$1.9M |
|
1354
BOK Financial
BOKF
$8.74B
| $4.71M | ﹤0.01% |
54,435
+6,348
| +13% | +$567K |
|
|
PCH
1355
DELISTED
PotlatchDeltic
PCH
| $4.7M | ﹤0.01% |
88,457
-1,188
| -1% | -$68.5K |
|
1356
Kirby Corp
KEX
$6.93B
| $4.7M | ﹤0.01% |
77,476
+2,727
| +4% | +$176K |
|
1357
Alarm.com
ALRM
$2.85B
| $4.7M | ﹤0.01% |
55,446
+4,388
| +9% | +$375K |
|
|
NXRT
1358
NexPoint Residential Trust
NXRT
$652M
| $4.68M | ﹤0.01% |
85,176
+403
| +0.5% | +$20.7K |
|
|
ARNC
1359
DELISTED
Arconic Corporation
ARNC
| $4.68M | ﹤0.01% |
131,447
+15,344
| +13% | +$507K |
|
1360
Trupanion
TRUP
$1.18B
| $4.67M | ﹤0.01% |
40,533
+2,538
| +7% | +$221K |
|
1361
Abercrombie & Fitch
ANF
$5B
| $4.65M | ﹤0.01% |
100,117
+5,026
| +5% | +$203K |
|
|
GTM
1362
ZoomInfo Technologies
GTM
$1.22B
| $4.65M | ﹤0.01% |
89,077
+14,830
| +20% | +$697K |
|
1363
Cracker Barrel
CBRL
$1.29B
| $4.6M | ﹤0.01% |
30,976
+1,942
| +7% | +$312K |
|
1364
Instil Bio
TIL
$50.3M
| $4.6M | ﹤0.01% |
+11,898
| New | +$4.41M |
|
1365
Iovance Biotherapeutics
IOVA
$2.87B
| $4.58M | ﹤0.01% |
175,911
-134,088
| -43% | -$3.49M |
|
1366
Korn Ferry
KFY
$4.28B
| $4.57M | ﹤0.01% |
62,987
+2,583
| +4% | +$172K |
|
1367
Vroom Inc
VRM
$48.2M
| $4.55M | ﹤0.01% |
1,359
+195
| +17% | +$663K |
|
1368
Grupo Cibest SA
CIB
$21.1B
| $4.54M | ﹤0.01% |
157,766
| – | – |
|
|
AHRT
1369
AH Realty Trust
AHRT
$517M
| $4.54M | ﹤0.01% |
341,679
-1,733
| -0.5% | -$23.2K |
|
1370
Kinsale Capital Group
KNSL
$8.51B
| $4.54M | ﹤0.01% |
27,559
+1,216
| +5% | +$201K |
|
1371
Outfront Media
OUT
$5.5B
| $4.54M | ﹤0.01% |
191,825
-47,800
| -20% | -$1.11M |
|
1372
Range Resources
RRC
$8.95B
| $4.53M | ﹤0.01% |
270,455
+53,585
| +25% | +$672K |
|
1373
Viasat
VSAT
$11.1B
| $4.53M | ﹤0.01% |
90,817
+7,508
| +9% | +$373K |
|
1374
Viavi Solutions
VIAV
$9.66B
| $4.52M | ﹤0.01% |
256,226
+3,887
| +2% | +$65.6K |
|
|
RETA
1375
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.52M | ﹤0.01% |
31,954
-6,074
| -16% | -$686K |
|
Similar funds
UBS AM's Q2 2021 Portfolio in Review
As of Q2 2021, UBS AM held 2,827 positions worth $234B, up 3.3% from $226B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM withdrew a net $11.4B in Q2 2021, closing 76 positions and reducing 923 holdings. Its most notable exit was Seagate, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Vanguard Short-Term Treasury ETF worth $350M.
- UBS AM's largest Q2 2021 buy was Vanguard Short-Term Treasury ETF: 5,703,693 shares worth $350M.
- UBS AM added most to Cisco in Q2 2021, an estimated $313M increase.
- UBS AM's biggest Q2 2021 reduction was Microsoft, cutting an estimated $3.16B.
- UBS AM fully exited Seagate in Q2 2021, selling an estimated $107M.
- UBS AM's ten largest holdings make up 21% of its $234B portfolio in Q2 2021.
- UBS AM opened 239 new positions and closed 76 in Q2 2021.
- UBS AM's portfolio value rose 3.3% quarter-over-quarter to $234B.
Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.